Stock markets in Europe are losing ground on Monday as investors are anxiously watching the latest updates on the conflict in the Middle East. In the cash market, the German DAX is currently down 0.54%, the French CAC40 is down 0.8% and the British FTSE100 is down 0.23%. Today, investors’ attention turns to the PMI data for June.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appVolatility currently observed in the broader European market. Source: xStation
The German DE40 index is losing ground today, although the instrument is still in the support zone of the 50-day exponential moving average (blue line on the chart). As long as the D40 stays above this zone, the overall uptrend remains stable (as indicated by the exponential moving averages). The 14-day RSI indicator is returning to the 45-point area. Source: xStation
Market news
Positive Phase I/II data for investigational antibody NXT007 in people with haemophilia A support its progression to Phase III clinical development, Roche said in a statement. Roche (ROG.CH) shares are down nearly 0.2% in today’s session.
Meanwhile, Novo Nordisk (NOVOB.DK) said the study suggests patients can safely switch to its experimental haemophilia drug from a competing Roche product. NOVOB shares are down 5% today.
Morgan Stanley says the reinsurance industry’s golden age is coming to an end, downgrading Munich Re (MUV2.DE) and Swiss Re (SREN.CH) to “underweight” ratings. The stocks are down 2% and 1%, respectively, in today’s session.
More news from individual DAX stocks. Source: Bloomberg Financial LP
This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
